GTII logo

Green Thumb Industries Inc. Stock Price

CNSX:GTII Community·CA$2.2b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 31 Fair Values set on narratives written by author

GTII Share Price Performance

CA$0
-8.10 (-100.00%)
CA$20.31
Fair Value
CA$0
-8.10 (-100.00%)
Price CA$0

GTII Community Narratives

·
Fair Value CA$20.31 51.2% undervalued intrinsic discount

Minnesota Launch And New Cannabis Markets Will Expand Footprint

0users have liked this narrative
0users have commented on this narrative
15users have followed this narrative
·
Fair Value CA$25.66 61.4% undervalued intrinsic discount

Federal Legalization And Wellness Trends Will Transform Cannabis Markets

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value CA$18.45 46.3% undervalued intrinsic discount

Regulatory Uncertainty And Oversupply Will Hamper Progress Yet Spark Resilience

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
CA$18.45
46.3% undervalued intrinsic discount
Revenue
3.98% p.a.
Profit Margin
4.25%
Future PE
51x
Price in 2029
CA$22.3
CA$25.66
61.4% undervalued intrinsic discount
Revenue
7.05% p.a.
Profit Margin
4%
Future PE
68.71x
Price in 2029
CA$31.01
CA$20.31
51.2% undervalued intrinsic discount
Revenue
4.93% p.a.
Profit Margin
1.66%
Future PE
142.35x
Price in 2029
CA$24.54

Trending Discussion

No trending discussion available.

Updated Narratives

GTII logo

GTII: Partial Rescheduling Order Will Support Future Upside In Key Markets

Fair Value: CA$18.45 46.3% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
GTII logo

GTII: Partial Cannabis Rescheduling Will Support Future Rerating Despite Medical Efficacy Concerns

Fair Value: CA$25.66 61.4% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
GTII logo

GTII: Rescheduling Order And Buybacks Will Support Higher Future Share Price

Fair Value: CA$20.31 51.2% undervalued intrinsic discount
15 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with solid track record.

1 Risk
4 Rewards

Green Thumb Industries Inc. Key Details

US$1.2b

Revenue

US$620.7m

Cost of Revenue

US$575.3m

Gross Profit

US$454.0m

Other Expenses

US$121.2m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 04, 2026
0.55
48.10%
10.14%
15.3%
View Full Analysis

About GTII

Founded
2014
Employees
4900
CEO
Benjamin Kovler
WebsiteView website
www.gtigrows.com

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, RYM, and RHYTHM brands. It distributes its products to third-party licensed retail customers; and sells finished products to third-party licensed retail cannabis stores. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.